Ishihara, L., Beck, M., Travis, S., Akintayo, O., & Brickel, N. (2015). Physician and Pharmacist Understanding of the Risk of Urinary Retention with Retigabine (Ezogabine): A REMS Assessment Survey. Drugs - real world outcomes, 2(4), 335-344. https://doi.org/10.1007/s40801-015-0042-5
Citace podle Chicago (17th ed.)Ishihara, Lianna, Melissa Beck, Sara Travis, Olusegun Akintayo, a Neil Brickel. "Physician and Pharmacist Understanding of the Risk of Urinary Retention with Retigabine (Ezogabine): A REMS Assessment Survey." Drugs - Real World Outcomes 2, no. 4 (2015): 335-344. https://doi.org/10.1007/s40801-015-0042-5.
Citace podle MLA (9th ed.)Ishihara, Lianna, et al. "Physician and Pharmacist Understanding of the Risk of Urinary Retention with Retigabine (Ezogabine): A REMS Assessment Survey." Drugs - Real World Outcomes, vol. 2, no. 4, 2015, pp. 335-344, https://doi.org/10.1007/s40801-015-0042-5.